The Intercept @theintercept
The Biden administration has so far declined to take a position on the waiver request and continued talks with pharmaceutical firms, which have fiercely opposed any waiver of IP rights to address the crisis. https://t.co/xY8s1ZcVmR — PolitiTweet.org